Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN FRANCISCO, April 24, 2001 (PRIMEZONE) -- On Wednesday, April 25, 2001, StreetFusion, the online network for financial events, will webcast quarterly earnings calls for the companies listed below....
-
SAN FRANCISCO, April 24, 2001 (PRIMEZONE) -- On Wednesday, April 25, 2001, StreetFusion, the online network for financial events, will webcast quarterly earnings calls for the companies listed below....
-
SAN FRANCISCO, April 24, 2001 (PRIMEZONE) -- On Wednesday, April 25, 2001, StreetFusion, the online network for financial events, will webcast quarterly earnings calls for the companies listed below....
-
Samalla parannetaan muurahaishapon johdannaistuotteiden tuotannon joustavuutta. Kemira odottaa suurinta kasvua juuri johdannaistuotteissa. Kemira investoi myös Kokkolan hienokemikaalituotannon...
-
SAN FRANCISCO, April 24, 2001 (PRIMEZONE) -- On Wednesday, April 25, 2001, StreetFusion, the online network for financial events, will webcast quarterly earnings calls for the companies listed below....
-
The Kemira Oyj Board of Directors has decided to start a programme for the purchase of the company’s own shares based on the authorization granted by the annual general meeting of shareholders on 3...
-
Valtuutuksen mukaan yhtiöllä on mahdollisuus ostaa markkinoilta Helsingin Arvopaperipörssin välityksellä kulloinkin vallitsevaan hintaan yhteensä enintään 6 118 000 yhtiön osaketta. Tämä vastaa 5 %...
-
STOCKHOLM, Sweden, April 24, 2001 (PRIMEZONE) -- Intentia's (XSSE:INT B) first quarterly report for 2001 will be released on Wednesday, April 25, at approximately 2:00 PM CET (GMT+1). Please join...
-
The clinical Phase 1 study on Active Biotech’s SAIK-MS compound, ABR-215062 in healthy volunteers and MS patients is concluded. The study has successfully reached its clinical endpoint, and has...
-
Den kliniska Fas I-studien av Active Biotechs substans SAIK-MS (ABR-215062), där friska frivilliga personer och MS-patienter deltagit, har nu avslutats. Det kliniska målet för studien har uppnåtts...